Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Xiao-Jun Huang |
| Publication date | February 27, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |